Generics [UK] Limited has enjoyed phenomenal
growth over the past five years, resulting from a comprehensive
reorganisation of the company and a refocusing of objectives.
The main strategic change was to broaden
the customer base, whilst maintaining a commitment to support
wholesale activity. To this end, Generics [UK] Limited is now
the generic company of choice for the majority of UK wholesalers
and this has led to an impressive increase in sales of Generics
[UK] Limited label products.
Although pricing is always an
important factor in the generic industry, service levels have
a significant impact on customer loyalty. Due to the company's
diverse manufacturing capabilities, Generics [UK] Limited is
able to control the manufacture of more than 80% of the product
range, thus optimising stock control and achieving consistently
high service levels.
New products are the lifeblood
of any generic company and accordingly, the introduction of
several new products over the past year has significantly influenced
overall sales. Generics [UK] Limited has many more "first to
market" generic products in the pipeline, which will ensure
that the company maintains its premier position in the UK.
"First to market" is the key focus of the marketing department. The UK Marketing Division works closely with the Technical Departments and Global Business Development, to identify opportunities at an early stage and to ensure we launch products on day one of patent expiry.
Our continued success lies with our ability to launch new
products into the market place before our competitors,
ensuring we remain the Number One UK generic supplier. New
products remain the lifeblood of any generic
company.
Our extensive product range consists
of over 300 lines, details of which are available from our product
guide and new product information below.